Article Details
Retrieved on: 2022-12-31 14:29:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
New Delhi: Pharmaceutical major, AstraZeneca has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug ...
Article found on: medicaldialogues.in
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here